Top compounds associated with response to SPRYD3


Feature Type Standardized
Nominal ANOVA
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.11 0.0009
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.0009
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0009
mRNA PD-0325901 gCSI pan-cancer AAC 0.18 0.0009
mRNA apicidin CTRPv2 pan-cancer AAC -0.1 0.001
mRNA ML162 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.13 0.001
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA nelarabine CTRPv2 pan-cancer AAC -0.13 0.001
mRNA fingolimod CTRPv2 pan-cancer AAC -0.12 0.002
Download CSV